Developed US market entry options for a mid-sized public European pharmaceutical company

A mid-sized public European pharma company wanted to develop and implement a strategy to enter the US market. TCG completed a thorough situation/market analysis and recommended a number of entry options, including target acquisitions and potential strategic partnerships. A US strategic partnership is now in place and the company is considering the acquisition candidates provided by TCG.